About Us

Fred Appelbaum, M.D., Director, Clinical Research

Fred Appelbaum

Dr. Fred Appelbaum is director of the Clinical Research Division at Fred Hutchinson Cancer Research Center and head of the Division of Medical Oncology at University of Washington. He has also served as the executive director of the Seattle Cancer Care Alliance since its formation in 1998.

In these roles, Appelbaum has responsibility for clinical sciences activities at the Hutchinson Center and UW in general, and serves as an adviser for the clinical sciences components of this interdisciplinary research program.

Appelbaum received his M.D. degree from Tufts University School of Medicine in 1972. He joined the Hutchinson Center and UW in 1978 after spending four years at the National Cancer Institute.

Appelbaum's own work centers on the biology and treatment of acute myeloid leukemia. He is the principal investigator of grant NCI PO1 CA 18029 ("Adult Leukemia Research Center") and serves as chair of the Southwest Oncology Leukemia Committee. He is the author of more than 800 publications dealing mostly with hematological malignancies.

Appelbaum is the principal investigator on the Fred Hutchinson/University of Washington oncology training grant. He also has had a role in many of the national hematology/oncology organizations and recently served as the chair of the Board of Scientific Advisors for the National Cancer Institute.

Learn more about the Clinical Research Division ยป

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.